v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning Balance at Dec. 31, 2020 $ 559,441   $ 180,892 $ 24,387   $ (6,052) $ 0 $ 360,214  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 106,498             106,498  
Dividends declared (13,280)             (13,280)  
Other comprehensive income (loss), net of tax 1,923         1,923      
Stock repurchases under buyback program (21,550)           (21,550)    
Repurchase of shares for tax payments related to the vesting and exercising of share-based grants (14,885)   (14,885)            
Issuance of shares in connection with a business combination 10,211   10,211            
Issuance of shares upon exercise of common stock options 4,577   4,577            
Stock-based compensation expense 10,336   10,336            
Ending Balance at Jun. 27, 2021 $ 643,271   191,131 24,387   (4,129) (21,550) 453,432  
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]                
Beginning Balance at Dec. 31, 2020 $ 559,441   180,892 24,387   (6,052) 0 360,214  
Ending Balance at Dec. 31, 2021 767,557 $ (43,693) 196,383 59,668 $ (59,668) (2,228) 0 513,734 $ 15,975
Beginning Balance at Mar. 28, 2021 595,275   174,920 24,387   (5,136) 0 401,104  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 58,985             58,985  
Dividends declared (6,657)             (6,657)  
Other comprehensive income (loss), net of tax 1,007         1,007      
Stock repurchases under buyback program (21,550)           (21,550)    
Repurchase of shares for tax payments related to the vesting and exercising of share-based grants (421)   (421)            
Issuance of shares in connection with a business combination 10,211   10,211            
Issuance of shares upon exercise of common stock options 383   383            
Stock-based compensation expense 6,038   6,038            
Ending Balance at Jun. 27, 2021 643,271   191,131 24,387   (4,129) (21,550) 453,432  
Beginning Balance at Dec. 31, 2021 767,557 $ (43,693) 196,383 59,668 $ (59,668) (2,228) 0 513,734 $ 15,975
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 229,197             229,197  
Dividends declared (15,263)             (15,263)  
Other comprehensive income (loss), net of tax 711         711      
Stock repurchases under buyback program (41,309)   (5,478)         (35,831)  
Repurchase of shares for tax payments related to the vesting and exercising of share-based grants (10,035)   (10,035)            
Issuance of shares upon exercise of common stock options 181   181            
Stock-based compensation expense 10,244   10,244            
Ending Balance at Jun. 26, 2022 897,590   191,295 0   (1,517) 0 707,812  
Beginning Balance at Mar. 27, 2022 799,972   188,433 0   (1,442) 0 612,981  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 116,524             116,524  
Dividends declared (7,579)             (7,579)  
Other comprehensive income (loss), net of tax (75)         (75)      
Stock repurchases under buyback program (16,530)   (2,416)         (14,114)  
Repurchase of shares for tax payments related to the vesting and exercising of share-based grants (36)   (36)            
Issuance of shares upon exercise of common stock options 181   181            
Stock-based compensation expense 5,133   5,133            
Ending Balance at Jun. 26, 2022 $ 897,590   $ 191,295 $ 0   $ (1,517) $ 0 $ 707,812